Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mann

Showing results (361-370 of 377) with videos related to

Pageof 38
Sort By:
Contemporary Clinical Trials|November 9, 2018
European paediatric non-alcoholic fatty liver disease registry (EU-PNAFLD): Design and rationaleJake P Mann, Anita Vreugdenhil, Piotr Socha, et al.
International Journal of Cancer|November 1, 2014
Chromosome instability in diffuse large B cell lymphomas is suppressed by activation of the noncanonical NF-κB pathwaySampath Ramachandiran, Arsene Adon, Xiangxue Guo, et al.
Osteoarthritis and Cartilage Open|January 13, 2025
Tibiofemoral cartilage strain and recovery following a 3-mile run measured using deep learning segmentation of bone and cartilagePatrick X Bradley, Sophia Y Kim-Wang, Brooke S Blaisdell, et al.
Pain Physician|July 29, 2015
A Systematic Review and Best Evidence Synthesis of the Effectiveness of Therapeutic Facet Joint Interventions in Managing Chronic Spinal PainLaxmaiah Manchikanti, Alan D Kaye, Mark V Boswell, et al.
Hepatology Communications|April 12, 2022
Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17-beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanismsChristian A Hudert, Leon A Adams, Anna Alisi, et al.
Cancer Research|May 1, 2010
Sustained small interfering RNA delivery by mesoporous silicon particlesTakemi Tanaka, Lingegowda S Mangala, Pablo E Vivas-Mejia, et al.
Oncogene|April 4, 2017
Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotypeX Guo, J L Koff, A B Moffitt, et al.
BMC Cancer|July 2, 2020
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myelomaTravers Ching, Megan E Duncan, Tera Newman-Eerkes, et al.
Journal of Hepatology|August 27, 2023
Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy livesAleksander Krag, Maria Buti, Jeffrey V Lazarus, et al.
The Journal of Molecular Diagnostics : JMD|January 24, 2016
Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal MalignanciesKevin E Fisher, Linsheng Zhang, Jason Wang, et al.
Pageof 38

Showing results (361-370 of 377) with videos related to

Sort By:
Pageof 38
Contemporary Clinical Trials|November 9, 2018
European paediatric non-alcoholic fatty liver disease registry (EU-PNAFLD): Design and rationaleJake P Mann, Anita Vreugdenhil, Piotr Socha, et al.
International Journal of Cancer|November 1, 2014
Chromosome instability in diffuse large B cell lymphomas is suppressed by activation of the noncanonical NF-κB pathwaySampath Ramachandiran, Arsene Adon, Xiangxue Guo, et al.
Osteoarthritis and Cartilage Open|January 13, 2025
Tibiofemoral cartilage strain and recovery following a 3-mile run measured using deep learning segmentation of bone and cartilagePatrick X Bradley, Sophia Y Kim-Wang, Brooke S Blaisdell, et al.
Pain Physician|July 29, 2015
A Systematic Review and Best Evidence Synthesis of the Effectiveness of Therapeutic Facet Joint Interventions in Managing Chronic Spinal PainLaxmaiah Manchikanti, Alan D Kaye, Mark V Boswell, et al.
Hepatology Communications|April 12, 2022
Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17-beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanismsChristian A Hudert, Leon A Adams, Anna Alisi, et al.
Cancer Research|May 1, 2010
Sustained small interfering RNA delivery by mesoporous silicon particlesTakemi Tanaka, Lingegowda S Mangala, Pablo E Vivas-Mejia, et al.
Oncogene|April 4, 2017
Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotypeX Guo, J L Koff, A B Moffitt, et al.
BMC Cancer|July 2, 2020
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myelomaTravers Ching, Megan E Duncan, Tera Newman-Eerkes, et al.
Journal of Hepatology|August 27, 2023
Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy livesAleksander Krag, Maria Buti, Jeffrey V Lazarus, et al.
The Journal of Molecular Diagnostics : JMD|January 24, 2016
Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal MalignanciesKevin E Fisher, Linsheng Zhang, Jason Wang, et al.
Pageof 38